Cardiovascular toxicity of targeted therapies for cancer: an overview of systematic reviews
Published on the 04 November 2020
Dr Marina van Leeuwen, a cancer epidemiologist in the Cancer Epidemiology Research Unit, has led new research that synthesises the evidence of cardiovascular toxicity of targeted therapies for cancer.
The findings may assist clinicians and patients when managing cardiovascular health.
The research was performed in collaboration with experts in oncology, cardiovascular disease and people affected by cancer.
This research has been published in the Journal of the National Cancer Institute Cancer Spectrum and the full article can be found here:
The accompanying Plain Language Summary and Table can be accessed here: